icrf 193 has been researched along with Chromosomal Instability in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Campbell, L; Chappell, S; Errington, RJ; Khan, IA; Marquez, N; Njoh, K; Silvestre, O; Smith, PJ; Wiltshire, M | 1 |
| Chappell, MJ; Chin, SF; Errington, RJ; Khan, IA; Njoh, K; Smith, PJ | 1 |
2 other study(ies) available for icrf 193 and Chromosomal Instability
| Article | Year |
|---|---|
Mitotic bypass via an occult cell cycle phase following DNA topoisomerase II inhibition in p53 functional human tumor cells.
Topics: Cell Cycle; Cell Line, Tumor; Chromosomal Instability; Cyclin B; Cyclin B1; Cytoplasm; Diketopiperazines; DNA Topoisomerases, Type II; Flow Cytometry; Green Fluorescent Proteins; Humans; Microscopy, Fluorescence; Mitosis; Piperazines; Topoisomerase II Inhibitors; Transfection; Tumor Suppressor Protein p53 | 2007 |
Cell cycle checkpoint-guarded routes to catenation-induced chromosomal instability.
Topics: Aneuploidy; Cell Cycle; Cell Line; Chromosomal Instability; Diketopiperazines; DNA, Catenated; Genes, cdc; Humans; Models, Theoretical; Neoplasms; Piperazines; Polyploidy; Topoisomerase II Inhibitors; Tumor Suppressor Protein p53 | 2008 |